Interleukin-15 induces antimicrobial activity after release by Cryptococcus neoformans stimulated monocytes

被引:33
作者
Mody, CH
Spurrell, JCL
Wood, CJ
机构
[1] Univ Calgary, Dept Internal Med, Calgary, AB T2N 4N1, Canada
[2] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada
基金
英国医学研究理事会;
关键词
D O I
10.1086/515381
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A newly described cytokine, interleukin (IL)-15, shares many activities with IL-2; however, little is known about the stimuli for release of IL-15, and its role in antimicrobial host defense has not previously been demonstrated. This study found that Cryptococcus neoformans is a potent stimulus for the release of biologically active IL-15 from monocytes. Both IL-15 and IL-2 made significant contributions to lymphocyte proliferation and lymphocyte-mediated anticryptococcal activity to encapsulated and acapsular C. neoformans. IL-15 restored lymphocyte proliferation and anticryptococcal activity that had been abrogated by blocking IL-2. IL-15 also enhanced the anticryptococcal activity of lymphocytes but did not enhance the activity of monocytes. This suggests that IL-15 and IL-2 cooperate for lymphocyte activation and proliferation in vitro and demonstrates that IL-15 can induce antimicrobial activity, Taken together, these data suggest that microbes, and in particular C. neoformans, are an important stimulus for IL-15 and that IL-15 may have an important role in induction of antimicrobial effector mechanisms.
引用
收藏
页码:803 / 814
页数:12
相关论文
共 51 条
[21]  
HUFFNAGLE GB, 1995, J IMMUNOL, V155, P4790
[22]  
Jonuleit H, 1997, J IMMUNOL, V158, P2610
[23]  
JULLIEN D, 1997, J IMMUNOL, V158, P850
[24]  
Kanegane H, 1996, BLOOD, V88, P230
[25]  
KOZEL TR, 1982, J IMMUNOL, V129, P1675
[26]   Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells [J].
Kumaki, S ;
Armitage, R ;
Ahdieh, M ;
Park, L ;
Cosman, D .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) :1235-1239
[27]   MECHANISMS OF INHIBITION OF CRYPTOCOCCUS-NEOFORMANS BY HUMAN-LYMPHOCYTES [J].
LEVITZ, SM ;
NORTH, EA ;
DUPONT, MP ;
HARRISON, TS .
INFECTION AND IMMUNITY, 1995, 63 (09) :3550-3554
[28]   DIRECT ACTIVITY OF HUMAN T-LYMPHOCYTES AND NATURAL-KILLER-CELLS AGAINST CRYPTOCOCCUS-NEOFORMANS [J].
LEVITZ, SM ;
DUPONT, MP ;
SMAIL, EH .
INFECTION AND IMMUNITY, 1994, 62 (01) :194-202
[29]   PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN-LEUKOCYTES STIMULATED BY CRYPTOCOCCUS-NEOFORMANS [J].
LEVITZ, SM ;
TABUNI, A ;
KORNFELD, H ;
REARDON, CC ;
GOLENBOCK, DT .
INFECTION AND IMMUNITY, 1994, 62 (05) :1975-1981
[30]   KILLING OF CRYPTOCOCCUS-NEOFORMANS BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS STIMULATED IN CULTURE [J].
LEVITZ, SM ;
FARRELL, TP ;
MAZIARZ, RT .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (05) :1108-1113